News Release

BAXTER ANNOUNCES LAUNCH OF SYNDEO PATIENT-CONTROLLED ANALGESIA SYRINGE PUMP

Intuitive User-Interface, Enhanced Safety Features and Robust Design Offers Clinicians Comprehensive Patient-Controlled Analgesia Device

DEERFIELD, Ill, October 14, 2003 - Baxter Healthcare Corporation announced today the launch of the Syndeo PCA Syringe Pump, the latest in its line of patient-controlled analgesia (PCA) devices. The Syndeo pump, which delivers pre-determined doses of pain medication to patients on a prescribed basis, was designed with significant human factor engineering input, which incorporates end-user needs, preferences and usage patterns into various stages of the design process. The Syndeo PCA Syringe Pump combines both an intuitive user interface with built-in safety checks and a durable design, with the intent of enabling more time to focus on patient care.

"Baxter has a longstanding commitment to designing products and delivery solutions that address clinicians' medication management needs while enhancing patient safety," said David F. Drohan, senior vice president and president of Baxter's Medication Delivery business. "This product, with its intuitive user interface and unique safety features, is another example of that commitment."

Advantages of Syndeo PCA Syringe Pump

The Syndeo PCA Syringe Pump offers clinicians a number of unique usability and safety features including:

• A simple medication programming sequence with built-in safety checks, configurable options for medication units, auto restarts, and dose tone and dose limits to help reduce the potential for programming errors.
   
• Built-in wireless infra-red technology that enables patient medication history to be beamed to PDA devices or downloaded directly to a hand-held, infra-red capable printer.
   
• An easy-to-read display with a large color touch screen, easy-to-navigate programming screens and high visibility with adjustable volume, contrast and brightness, and bright LED colors that highlight pump status.
   
• A durable design that features impact-resistant housing, a built in handle for easy transport, shock protected screen and electronics and enclosed syringe drive mechanism with no exposed parts.

Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE: BAX). Baxter assists health-care professionals and their patients with treatment of complex medical conditions, including cancer, hemophilia, immune disorders, kidney disease and trauma. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives. For more information about Baxter, please visit www.baxter.com.

(Syndeo and Baxter are registered trademarks of Baxter International Inc. and its affiliates.)

FOR ADDITIONAL INFORMATION: